Erythema in diseases classified elsewhere

L12_ERYTHINOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L54* Cause of death: ICD-10 — L54* 2 out of 7 registries used, show all original rules.	84
4. Check minimum number of events None	84
5. Include endpoints None	84
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	L12_ERYTHINOTH
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L54
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L54
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Erythema in diseases classified elsewhere based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	461	302	158
Only index persons	439	286	153
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	56.68	58.12	53.91
Only index persons	56.26	57.79	53.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	51	26
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	54.88	52.09	60.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
78: Matched controls
780

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L548, A692,

ICD-10 Finland

+∞

52.0

A69.2

ICD-10 Finland

Lyme disease

16.5

30.0

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

+∞

19.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

8.3

15.4

L54.0*I00

ICD-10 Finland

Erythema marginatum in acute rheumatic fever

+∞

8.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.8

6.9

100

J01CA04

ATC

amoxicillin; systemic

9.6

6.7

564

D07AB08

ATC

desonide; topical

4.9

6.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

7.08

12.16

2.2

1.3

64.43

—

au/ml

—

(40761535) Cells panel - Urine sediment

4.55

7.52

5.0

2.9

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

550

5.01

5.08

6.9

4.7

11.48

12.00

mm/h

0.15

509

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3.05

4.14

11.0

7.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

690

+∞

3.79

20.6

15.9

19.88

21.74

mg/l

0.24

568

(3023420) DNA double strand Ab [Units/volume] in Serum

4.12

3.71

1.9

1.6

10.40

5.83

iu/ml

—

(3000494) Fungus identified in Specimen by Culture

2.63

2.87

1.3

1.6

—

(40768443) Skin Pathology biopsy report

3.93

2.67

1.6

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3.77

2.57

2.8

1.4

1.10

1.18

g/l

—

(40758558) Short blood count panel - Blood

223

2.03

2.37

9.4

6.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.44

2.16

1.0

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.68

2.03

3.2

2.4

—

(3019150) Specific gravity of Urine by Refractometry

157

1.98

1.99

8.4

4.0

1.02

kg/l

0.09

110

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

559

2.41

1.99

11.5

8.3

76.75

78.25

u/l

0.17

526

(3001604) Monocytes [#/volume] in Blood

377

1.91

1.95

11.2

6.1

0.58

0.56

e9/l

0.23

332

(3006315) Basophils [#/volume] in Blood

377

1.91

1.95

11.3

6.2

0.04

e9/l

0.19

330

(3030467) Casts [#/volume] in Urine by Automated count

201

1.90

1.93

3.6

3.4

0.28

0.37

e6/l

0.25

148

(4024509) Urine culture

2.97

1.69

3.7

1.4

—

(3018095) Leukocytes [#/volume] in Urine

272

1.77

1.67

4.9

3.9

13.57

77.23

e6/l

1.12

192

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

493

1.94

1.66

3.8

3.3

54.00

47.03

u/l

0.24

463

(3009261) Glucose [Presence] in Urine by Test strip

389

1.79

1.64

6.3

4.1

0.00

estimate

—

(3015736) pH of Urine

303

1.74

1.60

6.0

3.7

6.57

6.24

0.82

175

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.35

1.59

3.5

3.1

0.64

0.65

0.05

(3015377) Calcium [Moles/volume] in Serum or Plasma

249

1.74

1.55

3.5

3.2

2.36

2.37

mmol/l

0.20

230

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.30

1.53

3.5

3.1

1.38

1.19

0.41

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

129

1.86

1.50

4.3

2.9

1.23

0.85

e6/l

0.36

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

138

1.83

1.47

1.3

42.63

11.96

u/ml

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2.87

1.46

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

649

2.42

1.46

5.8

6.0

1.97

1.92

mu/l

0.12

600

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.07

1.38

1.8

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

100

1.90

1.37

3.6

2.0

31.57

28.56

0.63

100

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.62

1.33

1.3

1.2

—

(3019060) Gas panel - Arterial blood

2.18

1.32

7.9

4.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

161

1.71

1.27

3.1

2.2

—

(3044640) Blood type and Crossmatch panel - Blood

223

1.65

1.27

2.8

2.3

—

(3000991) Gas panel - Venous blood

2.08

1.24

4.6

8.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

145

1.72

1.24

1.2

1.3

14.09

46.54

iu/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2.41

1.21

1.0

1.2

—

2.04

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2.41

1.21

1.0

1.2

—

3.11

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2.04

1.19

7.9

2.4

49.20

63.16

ml/min/173m2

—

(42870588) Differential panel, method unspecified - Blood

236

1.60

1.17

10.7

5.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.11

1.16

2.9

3.2

22.59

25.03

mmol/l

—

(3019309) Folate [Moles/volume] in Red Blood Cells

114

1.75

1.15

2.1

1.7

2026.17

1162.65

nmol/l

1.45

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

333

1.57

1.12

3.0

2.6

—

estimate

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

673

2.32

1.11

8.1

6.8

40.14

39.95

mmol/mol

0.06

630

(3029937) Albumin [Presence] in Urine by Test strip

213

1.58

1.06

7.1

3.8

0.00

estimate

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

151

1.64

1.06

1.4

1.7

485.76

438.76

pmol/l

0.31

130

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

288

1.54

1.05

7.0

4.1

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

387

1.54

1.03

6.7

4.0

0.00

estimate

—

(3018010) Neutrophils/Leukocytes in Blood

358

1.53

1.01

10.1

5.8

52.29

57.32

1.45

342

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

102

1.72

1.00

4.3

4.6

27.80

33.68

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

291

1.52

0.99

5.3

3.9

21.94

32.93

ng/l

0.68

208

(3032080) INR in Blood by Coagulation assay

350

1.51

0.97

23.1

13.7

1.83

1.20

inr

0.54

282

(40768793) Breast Pathology biopsy report

0.00

0.97

0.0

1.3

—

(40768804) Tissue Pathology biopsy report

292

1.51

0.97

1.8

2.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.82

0.96

1.6

1.3

—

(3006504) Eosinophils/Leukocytes in Blood

352

1.49

0.93

10.9

5.8

2.62

2.75

0.20

333

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

561

1.64

0.91

4.9

4.7

15.18

14.85

pmol/l

0.41

511

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.70

0.88

1.8

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

122

0.53

0.87

1.4

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.01

0.86

2.0

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.73

0.84

1.9

1.4

—

(3023368) Bacteria identified in Blood by Culture

205

1.48

0.83

3.4

4.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

380

1.44

0.79

6.9

4.0

0.00

estimate

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.66

0.78

2.3

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

118

1.56

0.77

2.4

1.8

—

(3022096) Basophils/Leukocytes in Blood

351

1.43

0.77

11.0

5.9

0.74

0.67

0.38

328

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.15

0.76

2.2

1.3

—

(3026008) Bacteria identified in Urine by Culture

218

1.44

0.75

4.6

3.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

662

1.81

0.75

5.7

4.5

1.46

1.26

mmol/l

1.34

608

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.91

0.69

2.6

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

176

1.44

0.67

8.0

5.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

114

1.51

0.65

2.8

2.7

0.81

0.82

mmol/l

0.08

107

(4034850) Laboratory test

1.77

0.65

19.0

12.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.61

0.0

1.2

—

0.56

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.2

—

1.58

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

694

1.81

0.60

6.8

5.4

1.48

1.50

mmol/l

0.16

641

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

0.86

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.60

0.0

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

313

1.35

0.59

1.9

2.1

1.54

1.34

mmol/l

0.58

257

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

324

1.34

0.57

1.8

2.1

109.08

98.41

pmol/l

0.33

171

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1.63

0.56

6.0

3.2

1.68

2.45

mmol/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

231

1.33

0.51

4.0

3.1

773.43

847.52

ng/l

0.09

195

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.46

0.50

1.7

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

696

1.76

0.48

6.7

5.5

4.81

4.67

mmol/l

0.59

644

(3018418) pH of Serum or Plasma

224

1.31

0.47

4.0

3.8

7.40

0.25

159

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.65

0.44

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

106

1.39

0.43

2.5

1.5

—

(1761868) Lipid panel - Serum or Plasma

295

0.78

0.42

2.3

3.5

—

(3012516) Albumin [Mass/volume] in Urine

266

1.27

0.42

4.0

3.2

13.95

49.81

mg/l

2.11

177

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.41

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.0

—

3.00

—

(3025941) Bacteria identified in Stool by Culture

1.50

0.41

1.4

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

116

1.36

0.41

4.5

3.0

1.46

3.76

e6/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

107

1.38

0.40

1.3

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.37

0.39

1.8

2.5

0.26

0.22

g/l

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

163

1.31

0.39

1.7

1.53

1.06

mg/l

0.23

132

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.50

0.37

8.8

9.3

24.38

24.95

mmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

408

1.24

0.37

2.8

2.7

—

(3009343) pH of Capillary blood

1.39

0.35

6.7

3.0

7.42

7.43

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.36

0.34

1.2

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1.36

0.34

6.7

3.0

4.98

5.24

kpa

—

(3042936) Bacteria identified in Isolate by Culture

1.36

0.34

2.8

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1.33

0.31

1.3

1.5

1.47

1.17

g/l

—

(3009508) Creatinine [Moles/volume] in Urine

275

1.21

0.30

3.8

3.1

7.13

7.88

mmol/l

0.38

239

(3014576) Chloride [Moles/volume] in Serum or Plasma

113

1.29

0.29

9.1

7.0

104.57

104.02

mmol/l

0.16

113

(4035726) Immunohistochemistry procedure

0.68

0.27

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

709

1.46

0.27

7.6

6.3

2.85

2.71

mmol/l

0.66

659

(3020682) Albumin/Creatinine [Ratio] in Urine

278

1.19

0.26

4.1

3.9

8.81

8.66

mg/mmol

0.01

177

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.30

0.23

1.8

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.30

0.23

1.4

1.6

—

(3003694) ABO and Rh group [Type] in Blood

193

1.19

0.23

1.4

—

(3021589) Normoblasts [#/volume] in Blood

340

1.17

0.23

11.7

12.0

0.00

e9/l

0.50

284

(3019832) Treponema pallidum Ab [Presence] in Serum

1.23

0.22

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.32

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(4268621) Lupus anticoagulant assay

0.00

0.21

0.0

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.21

0.0

4.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

4.5

—

21.14

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.00

0.21

0.0

1.4

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

1.8

—

10.25

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.21

0.0

1.3

—

(40761536) Microorganisms panel - Urine sediment

1.30

0.21

2.5

3.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

4.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.20

0.0

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.20

0.0

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.19

0.20

1.2

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.27

0.20

1.3

4.3

2.36

7.85

ug/l

—

(3021960) Folate [Moles/volume] in Serum or Plasma

215

1.17

0.19

1.5

1.8

26.98

20.63

nmol/l

0.70

185

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.17

0.19

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.23

0.19

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.75

0.17

1.2

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

1.12

0.16

6.5

3.5

103.25

73.55

e9/l

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

580

0.88

0.14

20.7

20.0

13.87

13.72

0.37

575

(3002256) Pathology report gross observation

1.20

0.14

1.3

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

124

1.16

0.12

2.5

2.38

2.32

g/l

0.12

113

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.17

0.10

1.4

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

166

1.11

0.08

1.6

1.3

1.82

2.36

g/l

0.95

(40768797) Stomach Pathology biopsy report

1.07

0.07

1.2

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

212

0.92

0.06

3.3

3.9

0.00

estimate

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

210

1.07

0.04

5.1

5.7

3.67

1.64

ug/l

1.08

188

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

182

0.99

0.00

1.5

1.2

0.53

2.61

u/ml

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

117

1.03

0.00

2.4

2.5

25.56

20.55

0.81

110

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

163

0.98

0.00

3.4

4.6

18.04

21.37

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

127

1.03

0.00

2.6

3.2

0.92

0.70

ug/l

—

(3022145) Colonoscopy Study observation

1.05

0.00

1.2

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

26.8

—

1347.60

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.6

—

4.45

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

-0.00

0.0

3.0

—

45.60

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

6.4

—

1044.13

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

7.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

-0.00

0.0

1.7

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

2.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

20.6

—

921.60

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.0

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

2.2

—

36.92

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.6

—

10.48

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

5.73

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.97

-0.00

2.3

3.3

—

(36660697) Celiac disease serology panel - Serum

0.90

-0.00

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.5

—

29.05

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

92.33

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

12.7

—

7.17

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

-0.00

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.2

—

7.50

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.00

-0.00

3.6

2.0

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

-0.00

0.0

2.4

—

142.60

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

180.26

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTHINOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHINOTH.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTHINOTH – Erythema in diseases classified elsewhere

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Erythema in diseases classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints